Search filters

List of works by Elena De Mattia

A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy

scientific article published on 04 October 2018

A Pharmacogenetic Survey of Androgen Receptor (CAG)N and (GGN)N Polymorphisms in Patients Experiencing Long Term Side Effects after Finasteride Discontinuation

article

A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer

scientific article published on 09 November 2019

Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients.

scientific article published on 13 April 2018

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress

scientific article published on 22 September 2016

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress

scientific article published on 22 December 2016

CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions

scientific article published on 01 September 2020

Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients' Management and Therapy Outcomes ⬇️

scientific article published on 05 November 2019

Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)

scientific article published on 01 October 2019

Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype.

scientific article published on 11 January 2017

FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy.

scientific article published on 4 April 2019

Genetic biomarkers for hepatocellular cancer risk in a caucasian population.

scientific article published on September 2017

Genetic markers of the host to predict the efficacy of colorectal cancer targeted therapy

scientific article published on 12 July 2019

Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer

scientific article published on 28 December 2009

Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI

scientific article published on 26 November 2019

Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients

scientific article published on 10 September 2019

HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.

scientific article published on 3 December 2015

HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.

scientific article

Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation

scientific article published on 10 July 2018

Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS).

scientific article published on 18 May 2018

Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L.

scientific article published on 10 October 2017

MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer.

scientific article

MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin

scientific article published on 21 October 2014

New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach

scientific article published on 14 June 2019

Nuclear receptors and drug metabolism for the personalization of cancer therapy

scientific article

Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer

scientific article published on 08 September 2020

Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.

scientific article published on 05 September 2016

Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.

scientific article published in October 2013

Pharmacogenetics of the nuclear hormone receptors: the missing link between environment and drug effects?

scientific article published on December 2013

Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma

scientific article published on 01 August 2019

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment

scientific article published on 14 July 2017

Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.

scientific article published on 22 May 2015

Pharmacology of epidermal growth factor inhibitors.

scientific article published in January 2007

Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients

scientific article published on 26 February 2016

Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.

scientific article

Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine.

scientific article

The genotype for DPYD risk variants in colorectal cancer patients and the related toxicity management costs in clinical practice

article

Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy

scientific article published on 06 April 2010

UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population

scientific article published on 12 March 2017

rs4143815-PDL1, a New Potential Immunogenetic Biomarker of Biochemical Recurrence in Locally Advanced Prostate Cancer after Radiotherapy.

scientific article published on 27 April 2019

Paulina is supported by:

About Paulina

Help